Search hospitals > Idaho > Coeur D Alene
Kootenai Health - Coeur d'Alene
Claim this profileCoeur D Alene, Idaho 83814
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
260 reported clinical trials
4 medical researchers
Summary
Kootenai Health - Coeur d'Alene is a medical facility located in Coeur D Alene, Idaho. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Kootenai Health - Coeur d'Alene is involved with conducting 260 clinical trials across 431 conditions. There are 4 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, Todd Hoopman, MD, and Brook Lang, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
John M. SchallenkampBenefis Healthcare- Sletten Cancer Institute4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
177 reported clinical trials
254 drugs studied
Benjamin T. MarchelloKalispell Regional Medical Center8 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
6 reported clinical trials
20 drugs studied
Todd Hoopman, MDKootenai Health4 years of reported clinical research
Studies Lung Nodules
1 reported clinical trial
2 drugs studied
Brook Lang, MDKootenai Health3 years of reported clinical research
Studies Postpartum Depression
Studies Premature Labor
1 reported clinical trial
1 drug studied
Clinical Trials running at Kootenai Health - Coeur d'Alene
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Pancreatic Cancer
Anal Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Urothelial Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kootenai Health - Coeur d'Alene?
Kootenai Health - Coeur d'Alene is a medical facility located in Coeur D Alene, Idaho. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Kootenai Health - Coeur d'Alene is involved with conducting 260 clinical trials across 431 conditions. There are 4 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, Todd Hoopman, MD, and Brook Lang, MD.